Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.


Figure 3


Figure 3 Superoxide Production by Human Saphenous Veins From Patients With and Without Heart Failure

(A) Superoxide production by lucigenin-enhanced chemiluminescence. *p < 0.05 by Mann-Whitney test. (B) Relationship between superoxide and New York Heart Association (NYHA) functional class using a linear regression model adjusted for diabetes and renal failure. *p < 0.05. (C) Effect of various inhibitors on superoxide production in the control and heart failure groups. *p < 0.05 by analysis of variance followed by Scheffe test, to test for differences among interventions in either the control group or the heart failure group. DPI = diphenyleneiodonium; L-NAME = NG-nitro-L-arginine methyl ester. (D) Relationship between superoxide and C-reactive protein (CRP) levels; Pearson correlation: r = 0.501; p < 0.05.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement